LEI: 213800HAZOW1AWRSZR47
("REL" or the "Company")
Results of the Annual General Meeting ("AGM")
The Company is pleased to announce that, at the thirteenth AGM held at 17:00 (BST) on
The details of each resolution are as follows:
ORDINARY RESOLUTIONS
Resolution 1
IT WAS RESOLVED to receive and consider the annual audited financial statements of the Company for the year ended 31 December 2025.
For (including discretionary) | 1,363,644 votes |
Against | 74,804 votes |
Withheld* | 14 votes |
Resolution 2
IT WAS RESOLVED to re-appoint
For (including discretionary) | 1,361,780 votes | |
Against | 76,668 votes | |
Withheld* | 14 votes |
Resolution 3
IT WAS RESOLVED that the Board of Directors determine the remuneration of the Auditor.
For (including discretionary) | 1,438,448 votes | |
Against | 0 votes | |
Withheld* | 14 votes |
Resolution 4
IT WAS RESOLVED to re-elect Richard Horlick as a director.
For (including discretionary) | 1,331,578 votes | |
Against | 106,870 votes | |
Withheld* | 14 votes |
Resolution 5
IT WAS RESOLVED to re-elect Karen McClellan as a director.
For (including discretionary) | 1,407,745 votes | |
Against | 30,703 votes | |
Withheld* | 14 votes |
Resolution 6
IT WAS RESOLVED to re-elect John Roche as a director.
For (including discretionary) | 1,407,745 votes | |
Against | 30,703 votes | |
Withheld* | 14 votes |
*A vote withheld is not a vote in law and is therefore not counted towards the proportion of votes "for" or "against" the Resolution.
About
The Company is a closed-ended investment company which invests in the energy industry. Its ordinary shares are listed on the
For further details, see www.RiverstoneREL.com
Neither the contents of
Media Contacts
For
Deutsche Numis - Corporate Broker:
Hugh Jonathan / Matt Goss
+44 (0) 20 7260 1000
Company Secretary:
Birgitte Horn
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the

